Medication info

Glivia Tablet 100 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
Beige, round, biconvex film-coated tablet
Packaging
28 tablets (14 tablets/PTP * 2)
Approval status
Expired

MFDS item code 201502368 · Approved 2015.04.17

This product's status changed to Expired on 2025.04.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
When used as monotherapy or in combination therapy, this drug is administered at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes who are following a diet and exercise regimen. It can be administered as monotherapy and is also suitable for patients newly receiving diabetes medication. If sufficient blood sugar control cannot be achieved with monotherapy, it may be combined with metformin. Additionally, this medication can be added when used alone or in combination with sulfonylureas, metformin, thiazolidinediones, or insulin, but blood sugar control remains inadequate. Therefore, this medication helps improve blood sugar control when used in conjunction with various diabetes treatment methods.

How to take

Adult dose

When used as monotherapy or in combination therapy, this drug is administered at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered without regard to the timing of dialysis.

Precautions

This medication may rarely cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking it, you should stop taking it immediately and seek medical attention. Furthermore, this medication may cause inflammation of the pancreas, known as acute pancreatitis, during treatment. If symptoms such as abdominal pain, vomiting, or loss of appetite occur, you should visit a medical facility immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and patients who have a hypersensitivity to this medication or its components should avoid taking it. Patients with impaired kidney function may need dose adjustments for this medication, so kidney function tests should be performed before use, and patients should follow their doctor's instructions. Side effects such as upper respiratory infections, nasopharyngitis, headaches, and diarrhea may occur during treatment, and if symptoms persist or worsen, consultation with a physician is recommended. When used in conjunction with insulin or sulfonylurea medications, there may be an increased risk of hypoglycemia, so blood sugar changes should be closely monitored, and dosage adjustments should be made when necessary. This medication is not recommended for women who are pregnant or breastfeeding, and its safety in children and adolescents under 18 years of age has not been established. In elderly patients, kidney function may decline, so it is advisable to regularly monitor kidney function before and during treatment. In case of overdose, general emergency measures should be implemented, and blood dialysis may be used to remove some of the medication, if necessary. This medication tends to have few interactions with other drugs, but it is safe to consult a doctor when taking certain medications. If sudden joint pain or skin blisters occur during treatment, stop taking it immediately and consult a specialist.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, ideally at a temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

Beige, round, biconvex film-coated tablet

Package unit

28 tablets (14 tablets/PTP * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.